RevMedica Gains FDA Safer Technologies Program (STeP) Acceptance and Expands IP Portfolio

RevMedica becomes the only Endo Stapling Platform accepted into FDA's STeP. The Company also expands its intellectual property protection with 5 new patents. MIDDLETOWN, Conn., Jan. 22, 2025 /PRNewswire/ -- RevMedica™, Inc. is pleased to announce its' Endo Stapling Platform has been...